Histopathology Following CCH Injection

Clinical trial NCT04236635 · COMPLETED

Trial details

NCT number: NCT04236635
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Characteristics of Subcutaneous Tissue

Start date: 2019-12-20
Primary completion: 2020-09-23
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.